LOPHORA RECEIVES APPROVAL FROM EMA TO INITIATE PHASE I CLINICAL TRIAL FOR LPH-5, A PROMISING TREATMENT FOR DEPRESSION 17 September 2024
Lophora, a clinical-stage CNS drug discovery company developing novel, next generation 5HT2ARA therapeutics... Read more